Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
about
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamilyA robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinomaExpression Profile of Genes Related to Drug Metabolism in Human Brain TumorsCancerEST: a web-based tool for automatic meta-analysis of public EST dataOn Predicting lung cancer subtypes using 'omic' data from tumor and tumor-adjacent histologically-normal tissue.Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimensComparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR.S100P: a novel therapeutic target for cancer.Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissuesThe discovery of putative urine markers for the specific detection of prostate tumor by integrative mining of public genomic profiles.Elevated serum annexin A1 as potential diagnostic marker for lung cancer: a retrospective case-control study.A novel method for finding non-small cell lung cancer diagnosis biomarkers.Identification and verification of Hsp90-beta as a potential serum biomarker for lung cancer.Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assayValidation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specificThe state of molecular biomarkers for the early detection of lung cancer.Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.Clinical impact of high-throughput gene expression studies in lung cancer.Increased level of Hsp90-beta in bronchoalveolar lavage fluid correlates with lymphatic invasion and advanced stage of lung cancer patients.Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture.Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane.Identification of differentially-expressed genes between early-stage adenocarcinoma and squamous cell carcinoma lung cancer using meta-analysis methods.Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.Chitosan combined with molecular beacon for mir-155 detection and imaging in lung cancer.AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant CancersAldehyde dehydrogenase 1A1 increases NADH levels and promotes tumor growth via glutathione/dihydrolipoic acid-dependent NAD+ reduction.Exposure of mice to secondhand smoke elicits both transient and long-lasting transcriptional changes in cancer-related functional networks.AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer.
P2860
Q24655095-4E1A3271-D7DE-4E09-9ADE-85AAAAC636AAQ28385552-FD9FD844-166C-4AFB-AFDF-889AEA45631CQ28551028-0819BC84-B611-47F0-9CB9-EFD507B2F887Q30796869-C0AFB9FB-4D2D-4DBA-9186-8265954ADBBCQ31053216-E0458103-BDDA-4898-BA4F-C86943EEF0B0Q33384993-FF78F189-48FB-463B-B5FD-89087C3EF1F2Q33634644-3F78F1A0-1D55-4C7E-8E4B-EE3EB06F4445Q33699305-8A947BFC-1BF9-446A-B6EC-6B1688A21177Q34076679-D6B4B2B5-F424-4509-A2A1-7417FDEFD259Q34110104-678532CA-E3DE-4211-A68F-105E3CAAB2C4Q34420604-15BD9CB0-D62D-4324-9585-2B591B7F2E70Q34569997-7B92E2CF-25FD-4061-B866-B7F4A3903694Q34704972-7482DBFB-6CDC-4F25-A2FF-D2F547B28C5BQ35145259-71861220-24B3-461D-A9FC-96E4CA380888Q35830723-B2FD1C67-25C0-4FF8-BA0A-77E9BEC13E9BQ36022437-4271A52F-F08A-4AB5-AF0B-0359F32541F1Q36260566-F98B7C92-B241-465E-A789-3CDD29515CB6Q37044593-0594796C-2D41-4BF4-8030-8B32E10D49A1Q37105040-26623B67-8103-438F-A124-9B2CC3C7F403Q37317171-9E12992B-565E-47D2-A42C-D6115FB04019Q37393405-83A22D05-2C55-492B-B4A1-FBF3F4FC7DC7Q37714772-8C91D1B5-38D8-42E2-9532-6E75C0DD44E1Q37716406-0E471DE2-B079-4956-9131-A0ED07B06564Q37741998-DF48C2F1-DBD4-40C6-A920-BC56E019152CQ38433438-F6B599B4-605D-42E2-9920-1576C960F2DAQ38696133-774ADC09-5ECD-486B-9FD8-C05DA369B321Q38955717-A3A28D24-D0E1-4B96-9A1C-A15670072DD0Q39357739-26F49855-225B-4CCC-A56F-E80F5903D9BDQ39416839-512E627C-0A7F-4516-97E1-CF00E2B61F19Q40752477-28C5457D-EC76-4E01-836D-DEEF26BBA5F2Q42078803-2E73F76F-9E56-4931-A593-69DF7BD76509Q46331483-5723B8E7-7DBB-4778-A213-4AD043DFE882Q54364816-430B960D-4074-41BB-9D73-EAE07996407DQ55058467-70F1CB62-989C-49FA-B753-789AE4A836AB
P2860
Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical validity of the lung ...... sis of public expression data.
@ast
Clinical validity of the lung ...... sis of public expression data.
@en
type
label
Clinical validity of the lung ...... sis of public expression data.
@ast
Clinical validity of the lung ...... sis of public expression data.
@en
prefLabel
Clinical validity of the lung ...... sis of public expression data.
@ast
Clinical validity of the lung ...... sis of public expression data.
@en
P2093
P1433
P1476
Clinical validity of the lung ...... sis of public expression data.
@en
P2093
Bumjin Kim
Dae-Soon Son
Hye Young Choi
Hyun Joo Lee
Jaesang Kim
Jhingook Kim
Jinseon Lee
Kwhanmien Kim
P304
P356
10.1158/0008-5472.CAN-07-0003
P407
P577
2007-08-01T00:00:00Z